Orchid Chemicals trades jubilantly on getting US FDA’s nod for Gemifloxacin Mesylate Tablets

18 Jun 2015 Evaluate

Orchid Chemicals & Pharmaceuticals is currently trading at Rs. 56.70, up by 7.35 points or 14.89% from its previous closing of Rs. 49.35 on the BSE.

The scrip opened at Rs. 54.00 and has touched a high and low of Rs. 57.40 and Rs. 52.55 respectively. So far 4,78000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 85.35 on 15-Jul-2014 and a 52 week low of Rs. 42.60 on 11-Jun-2015.

Last one week high and low of the scrip stood at Rs. 51.15 and Rs. 42.60 respectively. The current market cap of the company is Rs. 420.77 crore.

The promoters holding in the company stood at 44.04% while Institutions and Non-Institutions held 5.28% and 46.90% respectively.

Orchid Chemicals & Pharmaceuticals has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Gemifloxacin Mesylate Tablets (320mg) with 180 days of generic drug exclusivity.

Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).

Orchid Pharma Share Price

829.90 7.15 (0.87%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×